Kalaris is a clinical-stage biopharmaceutical company founded by Samsara BioCapital and focused on development of TH103, a novel, differentiated and potentially transformative therapy for patients ...
Upon completion of the Merger, pre-Merger AlloVir stockholders are expected to own approximately 25.05% of the combined company and pre-Merger Kalaris stockholders are expected to own ...
Kalaris is a clinical-stage biopharmaceutical company founded by Samsara BioCapital and focused on development of TH103 ... the Proxy Statement and other relevant materials to be filed with the SEC ...
A new company is hoping to create a coffee alternative from a native New Zealand plant. Zoffee founder and chief executive Jack Keeys says the idea first came to him a few years ago when he read an ...
Unearth all sorts of useful tech treasures with my free Cool Tools newsletter from ... which gives the company an interesting edge in this manner of measurement. Plus, the Cloudflare test gauges ...